Dr. Drakaki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2020 Santa Monica Blvd., Suite 600
Santa Monica, CA 90404Phone+1 310-829-5471Fax+1 310-829-5471
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
- Tufts Medical CenterResidency, Internal Medicine, 2007 - 2010
- University of Crete School of Health SciencesClass of 2006
Certifications & Licensure
- CA State Medical License 2013 - 2027
- MA State Medical License Active through 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- FELLOWSHIP/ GI ASCO MERITT AWARD ASCO, 2013
Clinical Trials
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
Publications & Presentations
PubMed
- Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, Ryan Denu, Walid Macaron
Journal for Immunotherapy of Cancer. 2025-03-03 - A study to learn how well enfortumab vedotin (EV) with pembrolizumab works and how safe it is in people with advanced urothelial cancer: a plain language summary of th...Thomas Powles, Begoña P Valderrama, Shilpa Gupta, Jens Bedke, Eiji Kikuchi
Future Oncology. 2025-03-01 - Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma.Rafee Talukder, Dimitra Rafailia Bakaloudi, Dimitrios Makrakis, Leonidas N Diamantopoulos, Thomas Enright
Clinical Genitourinary Cancer. 2025-02-01
Authored Content
- Association of Baseline Systemic Corticosteroid Use with Overall Survival and Time to Next Treatment in Patients Receiving Immune Checkpoint Inhibitor Therapy in Real-World US Oncology Practice for Advanced Non-Small Cell Lung Cancer, Melanoma, or Urothelial CarcinomaJune 2020
Press Mentions
- New Imaging Technique Accurately Detects Aggressive Kidney Cancer, Claims StudyOctober 21st, 2024
- New Imaging Technique Accurately Detects Aggressive Kidney CancerOctober 3rd, 2024
- Adjuvant Therapy for Improved Disease-Free Survival for Patients with Muscle-Invasive Urothelial Carcinoma Following Radical Surgery - Checkmate 274 - Petros GrivasMarch 28th, 2021
- Join now to see all
Grant Support
- Role of mir9 in liver oncogenesisUCLAPresent
Research History
- PhD/Identification of microRNA signature in liver oncogenesis2015 - Present
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: